Pharmaceutical Companies

Questions for Review 1. Pharmaceutical companies do have a responsibility to distribute drugs for a wretched cost in developing and poorer countries. Africas GDP, and per capita income is very let loose so they cannot afford to buy top quality medicines. One main argument for this approach is the aid epidemic in Africa. A main argument against this is that the treatment for support is very expensive to offer to a whole country for free. 2. The principal arguments of pharmaceutical companies that oppose making exceptions to IPR law for developing countries atomic number 18 national treatment that is equal of foreign and domestic nationals.Most-favored-nation treatment and the equal treatment of all WTO members. Also, proficient progress. One last argument is how to provide commensurate protection for this, and enforcing it. The arguments by NGOs and others to relax IPR laws are to curiosity trade pressure on poor countries in health care industry disputes. 3. I would express South Africas decision to levy duties on drug imports from western nations to have a contradict impact on the internationalist distribution of drugs to South Africa. If it is already expensive and hard to get drugs to AIDS patients in Africa, making them more expensive will not help. .In my opinion, I feel like this was an permit change of policy because it did lower prices on drugs. Some negative ramifications of this resolutions is that the price wouldnt drop low enough. 5. I do not think it was necessary to relax IPR rules in order to ensure that adequate supplies of AIDS medications would be available for distribution in the developing world because the US took initiative to sire high drug prices and low-quality health infrastructures. 6. MNCs have an ethical responsibility in providing funding to international organizations like the global fund to help cure AIDS